Trials / Unknown
UnknownNCT00306085
Autologous Bone Marrow Cell Treatment in Peripheral Atherosclerosis
Autologous Bone Marrow Cell Treatment in Patients With Peripheral Atherosclerosis
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (planned)
- Sponsor
- University of Naples · Academic / Other
- Sex
- All
- Age
- 45 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Implantation of bone marrow cells, including endothelial progenitor cells, into ischemic limbs has been shown to improve collateral vessel formation. In the present study the safety and feasibility of autologous blood mononuclear cells implantation will be investigated in patients with severe peripheral atherosclerosis.Twenty cases will be enrolled. Improvement in the ankle-brachial pressure index (ABI:\>0.1), ischemic ulcers and angiography as well as laser doppler flow will be evaluated until six months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | Autologous bone marrow cells |
Timeline
- Start date
- 2005-04-01
- Completion
- 2006-04-01
- First posted
- 2006-03-22
- Last updated
- 2006-03-22
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00306085. Inclusion in this directory is not an endorsement.